China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,224 | 77,548 | 144,139 | 131,497 | 147,265 |
| Marketable Securities | 30,388 | 30,188 | 6,609 | N/A | N/A |
| Receivables | 24,598 | 23,485 | 17,270 | 22,405 | 17,822 |
| Inventories | 94,813 | 90,712 | 88,635 | 83,677 | 80,908 |
| TOTAL | $261,985 | $230,528 | $264,293 | $244,059 | $251,497 |
| Non-Current Assets | |||||
| PPE Net | 76,967 | 75,319 | 73,149 | 67,126 | 62,337 |
| Investments And Advances | 13,127 | 11,588 | 11,350 | 11,652 | 10,937 |
| Intangibles | 13,679 | 12,924 | 8,213 | 9,879 | 9,477 |
| Other Non-Current Assets | 83,696 | 83,593 | 46,776 | 48,837 | 19,456 |
| TOTAL | $187,469 | $183,424 | $139,488 | $137,495 | $102,208 |
| Total Assets | $449,453 | $413,952 | $403,781 | $381,554 | $353,705 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 34,875 | 34,869 | 9,822 | 4,890 | 4,860 |
| Accounts payable and accrued liabilities | 42,045 | 39,599 | 49,414 | 37,895 | 32,970 |
| Other current liabilities | 4,578 | 1,535 | N/A | 2,101 | 2,381 |
| TOTAL | $86,034 | $81,264 | $63,439 | $50,369 | $43,544 |
| Non-Current Liabilities | |||||
| Long Term Debt | 70,000 | 70,000 | 30,000 | 30,000 | N/A |
| Other Non-Current Liabilities | -3,005 | -1,961 | 174 | -1,783 | -3,405 |
| TOTAL | $76,949 | $76,696 | $36,373 | $36,460 | $6,384 |
| Total Liabilities | $162,983 | $157,960 | $99,812 | $86,829 | $49,928 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,481 | 23,443 | 23,368 | 25,573 | 26,953 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 211,743 | 192,018 | 173,745 | 164,917 | 150,221 |
| Other shareholders' equity | 98,458 | 90,753 | 88,190 | 91,107 | 86,250 |
| TOTAL | $286,471 | $255,992 | $303,970 | $294,725 | $303,777 |
| Total Liabilities And Equity | $449,453 | $413,952 | $403,781 | $381,554 | $353,705 |